P8A:SGX
Cordlife Group Ltd
SGD 0.12
0.00%
(0.00) 1 دن
12 اکتوبر, 9:49:20 AM GMT +8 · SGD
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoP8A کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
مارکیٹ کی سرمایہ کاری
3.24 کروڑ
اوسط والیوم
1.32 ہزار
والیوم
0.00
52 ہفتے میں اعلی
SGD 0.26
52 ہفتے کا کم
SGD 0.10
EPS
-SGD 0.04
بقایہ شیئرز
26.75 کروڑ
ملازمین کی تعداد
111
مارکیٹ کی سرمایہ کاری
3.24 کروڑ
اوسط والیوم
1.32 ہزار
والیوم
0.00
52 ہفتے میں اعلی
SGD 0.26
52 ہفتے کا کم
SGD 0.10
EPS
-SGD 0.04
بقایہ شیئرز
26.75 کروڑ
ملازمین کی تعداد
111
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
Opening Bell Daily
·
1 گھنٹہ پہلے
Stock market after midterms: S&P 500 up all 19 times
FinanceFeeds
·
1 گھنٹہ پہلے
The Nasdaq Index Just Had Its Worst Week Since June - and Netflix, Tesla and Meta Report Next
Yahoo Finance
·
11 گھنٹے پہلے
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
1 دن پہلے
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
پروفائل
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Cordlife Group Ltd کے بارے میں
CEOYiu Pang Fai
ملازمین111
تاریخ قیام2 مئی، 2001
ہیڈ کواٹرز-
سیکٹرHealth care provider
ویب سائٹcordlife.com